Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1995;92:3453-3463

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carstensen, S.
Right arrow Articles by Saunamäki, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carstensen, S.
Right arrow Articles by Saunamäki, K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ATROPINE

(Circulation. 1995;92:3453-3463.)
© 1995 American Heart Association, Inc.


Articles

Dobutamine-Atropine Stress Echocardiography in Asymptomatic Healthy Individuals

The Relativity of Stress-Induced Hyperkinesia

Steen Carstensen, MD; Samir M. Ali, MD; Frank V. Stensgaard-Hansen, MD; Jens Toft, MD; Stig Haunsø, MD; Henning Kelbæk, MD; Kari Saunamäki, MD

From the Department of Medicine B (S.C., S.M.A., F.V.S.-H., S.H., H.K., K.S.) and the Copenhagen City Heart Study, Epidemiological Research Unit, Department 7121, and the Department of Clinical Physiology and Nuclear Medicine (J.T.), Rigshospitalet, University of Copenhagen (Denmark).

Correspondence to Steen Carstensen, MD, Department of Medicine B 2142, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, Copenhagen DK-2100, Denmark.

Background Interpretation of dobutamine-atropine stress echocardiography (DASE) is based on the assumption that the normal response to dobutamine-atropine infusion is characterized by increased systolic thickening and motion of the left ventricular (LV) walls, whereas a reduction or no change is considered indicative of coronary artery disease. The aim of this study was to quantitatively assess changes in LV dimension and wall motion patterns during DASE in a healthy population.

Methods and Results Forty-two asymptomatic voluntary subjects (22 men) with a mean age of 59 years (range, 31 to 79 years) and a likelihood of <5% for coronary artery disease underwent DASE with digital recording of two-dimensional and M-mode echocardiography at baseline and low-dose and peak infusion rates. Mean end-diastolic and end-systolic LV diameters and areas decreased and wall thicknesses increased progressively throughout the test. Wall motion and thickening increased from baseline to low-dose infusion in nearly all subjects. However, from low-dose to peak infusion, the mean absolute wall motion and relative wall thickening decreased by 13.1% (95% CI, 2.7 to 23.5) and 21.4% (95% CI, 6.4 to 36.4) regardless of age, sex, or use of atropine. Changes in fractional shortening and absolute wall thickening varied considerably, with a decrease observed in 15 and 13 individuals (36% and 31%), respectively.

Conclusions In healthy subjects, measures of wall motion and wall thickening increased from baseline to low-dose infusion but decreased from low-dose to peak infusion. These findings call for revision of the assumptions on which the common analysis of DASE is based.


Key Words: echocardiography • stress • dobutamine




This article has been cited by other articles:


Home page
Eur J EchocardiogrHome page
R. Sicari, P. Nihoyannopoulos, A. Evangelista, J. Kasprzak, P. Lancellotti, D. Poldermans, J.-U. Voigt, J. L. Zamorano, and on behalf of the European Association of Echocardi
Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC)
Eur J Echocardiogr, July 1, 2008; 9(4): 415 - 437.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. Paetsch, D. Foll, A. Kaluza, R. Luechinger, M. Stuber, A. Bornstedt, A. Wahl, E. Fleck, and E. Nagel
Magnetic resonance stress tagging in ischemic heart disease
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2708 - H2714.
[Abstract] [Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
S Carstensen, U Host, K Saunamaki, and H Kelbaek
Quantitative analysis of dobutamine-atropine stress echocardiography
Eur J Echocardiogr, September 1, 2003; 4(3): 169 - 177.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R. Hoffmann, T.H. Marwick, D. Poldermans, H. Lethen, R. Ciani, P. van der Meer, H.-P. Tries, P. Gianfagna, P. Fioretti, J.J. Bax, et al.
Refinements in stress echocardiographic techniques improve inter-institutional agreement in interpretation of dobutamine stress echocardiograms
Eur. Heart J., May 2, 2002; 23(10): 821 - 829.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
K. F. Kofoed, R. Bangsgaard, S. Carstensen, J. H. Svendsen, P. R. Hansen, H. Arendrup, B. Hesse, and H. Kelbaek
Prolonged ischemic heart disease and coronary artery bypass -- relation to contractile reserve
Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 417 - 423.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M.L Geleijnse, C Vigna, J.D Kasprzak, R Rambaldi, M.P Salvatori, A Elhendy, J.H Cornel, P.M Fioretti, and J.R.T.C Roelandt
Usefulness and limitations of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in patients with left bundle branch block. A multicentre study
Eur. Heart J., October 2, 2000; 21(20): 1666 - 1673.
[Abstract] [PDF]


Home page
CirculationHome page
D. A. Calnon, D. K. Glover, G. A. Beller, G. Vanzetto, W. H. Smith, D. D. Watson, and M. Ruiz
Effects of Dobutamine Stress on Myocardial Blood Flow, 99mTc Sestamibi Uptake, and Systolic Wall Thickening in the Presence of Coronary Artery Stenoses : Implications for Dobutamine Stress Testing
Circulation, October 7, 1997; 96(7): 2353 - 2360.
[Abstract] [Full Text]